SriyaWcGunawardenaMD

Pediatric Hematology & Oncology • Pittsburgh, PA

Associate Professor, Pediatrics, University of Pittsburgh School of Medicine

Join to view full profile

Dr. Gunawardena is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gunawardena's full profile

Already have an account?

Office
4401 Penn Ave
Pittsburgh, PA 15224
Phone+1 412-692-5055

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1992 - 1996
University of Texas at Austin Dell Medical SchoolResidency, Pediatrics, 1989 - 1991
Columbus HospitalInternship, Pediatrics, 1988 - 1989
University of Colombo Faculty of MedicineClass of 1981

Certifications & Licensure

PA State Medical License 1997 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014

Clinical Trials

Evaluation of the Duration of Therapy for Thrombosis in Children Start of enrollment: 2008 Mar 01
Completed
Phase 3

Publications & Presentations

PubMed

11 citations
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl
Journal of Thrombosis and Haemostasis. 2022-12-01
18 citations
First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results.
Christoph Königs, Margareth C Ozelo, Amy Dunn, Roshni Kulkarni, Beatrice Nolan
Blood. 2022-06-30
21 citations
Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B
Beatrice Nolan, Anna Klukowska, Amy D. Shapiro, Antoine Rauch, Michael Recht
Blood Advances. 2021-07-13

Lectures

Lyra: A Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (Cybord) in Newly Diagnosed and Relapsed Patients (Pts) with Multiple ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018